Clinicopathologic significance of tumor microenvironment CD11c, and FOXP3 expression in diffuse large B-cell lymphoma patients receiving rituximab, cyclophosphamide, anthracycline, vincristine, and prednisone (R-CHOP) combination chemotherapy

BACKGROUND/AIMS: CD11c is a dendritic cell marker in humans, which potentially induces a cytotoxic effect on lymphoma cells. Forkhead boxP3 (FOXP3) is a regulator of T lymphocyte in the microenvironment of the lymphoma. The principal objective of this study was to determine whether the tumors’ micro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seul, Kim, Dong Hyun, Oh, Sung Yong, Kim, So Yeon, Koh, Myeong Seok, Lee, Ji Hyun, Lee, Suee, Kim, Sung-Hyun, Kwak, Jong-Young, Pak, Min Gyoung, Ju, Mi Ha, Kim, Hyo-Jin, Jeong, Jin Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339461/
https://www.ncbi.nlm.nih.gov/pubmed/26968188
http://dx.doi.org/10.3904/kjim.2015.161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339461/
https://www.ncbi.nlm.nih.gov/pubmed/26968188
http://dx.doi.org/10.3904/kjim.2015.161

Ejemplares similares